Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients.

Engelhardt M, Domm AS, Dold SM, Ihorst G, Reinhardt H, Zober A, Hieke S, Baayen C, Müller SJ, Einsele H, Sonneveld P, Landgren O, Schumacher M, Wäsch R.

Haematologica. 2017 May;102(5):910-921. doi: 10.3324/haematol.2016.162693. Epub 2017 Feb 2.

2.

Geriatric assessment in multiple myeloma patients: validation of the International Myeloma Working Group (IMWG) score and comparison with other common comorbidity scores.

Engelhardt M, Dold SM, Ihorst G, Zober A, Möller M, Reinhardt H, Hieke S, Schumacher M, Wäsch R.

Haematologica. 2016 Sep;101(9):1110-9. doi: 10.3324/haematol.2016.148189. Epub 2016 Jun 16.

3.

Sleep changes in smokers before, during and 3 months after nicotine withdrawal.

Jaehne A, Unbehaun T, Feige B, Cohrs S, Rodenbeck A, Schütz AL, Uhl V, Zober A, Riemann D.

Addict Biol. 2015 Jul;20(4):747-55. doi: 10.1111/adb.12151. Epub 2014 May 4. Erratum in: Addict Biol. 2015 Nov;20(6):1056. Schütz, Anna-Lisa [added]; Uhl, Verena [added]; Zober, Alexander [added].

PMID:
24797355
4.

Impact of an occupational health promotion program on subsequent illness and mortality experience.

Ott MG, Yong M, Zober A, Nasterlack M, Messerer P, Pluto RP, Lang S, Oberlinner C.

Int Arch Occup Environ Health. 2010 Dec;83(8):887-94. doi: 10.1007/s00420-010-0521-7. Epub 2010 Feb 26.

PMID:
20186547
5.

Alanine-aminotransferase levels predict impaired glucose tolerance in a worksite population.

Oberlinner C, Zober A, Nawroth PP, Humpert PM, Morcos M.

Acta Diabetol. 2010 Jun;47(2):161-5. doi: 10.1007/s00592-009-0148-x. Epub 2009 Oct 24.

PMID:
19855923
6.

Medical program for shift workers--impacts on chronic disease and mortality outcomes.

Oberlinner C, Ott MG, Nasterlack M, Yong M, Messerer P, Zober A, Lang S.

Scand J Work Environ Health. 2009 Jul;35(4):309-18. Epub 2009 May 27.

7.

Health and safety protection for chemical industry employees in a rotating shift system: program design and acute injury and illness experience at work.

Ott MG, Oberlinner C, Lang S, Hoffmann G, Nasterlack M, Pluto RP, Trauth B, Messerer P, Zober A.

J Occup Environ Med. 2009 Feb;51(2):221-31. doi: 10.1097/JOM.0b013e318192bd0f.

PMID:
19209044
8.

Cancer incidence in the wastewater treatment plant of a large chemical company.

Nasterlack M, Messerer P, Pallapies D, Ott MG, Zober A.

Int Arch Occup Environ Health. 2009 Jul;82(7):851-6. doi: 10.1007/s00420-009-0397-6. Epub 2009 Feb 4.

PMID:
19190931
9.

Screening for pre-diabetes and diabetes in the workplace.

Oberlinner C, Neumann SM, Ott MG, Zober A.

Occup Med (Lond). 2008 Jan;58(1):41-5. Epub 2007 Nov 19.

PMID:
18025060
10.

Metabolic syndrome in a large chemical company: prevalence in a screened worksite sample.

Oberlinner C, Humpert PM, Nawroth PP, Zober A, Morcos M.

Acta Diabetol. 2008 Mar;45(1):31-5. Epub 2007 Sep 20.

PMID:
17882349
11.

Considerations on occupational medical surveillance in employees handling nanoparticles.

Nasterlack M, Zober A, Oberlinner C.

Int Arch Occup Environ Health. 2008 May;81(6):721-6. Epub 2007 Sep 12.

PMID:
17849141
12.

[Prevention of overweight and obesity in the workplace. BASF-health promotion campaign "trim down the pounds--losing weight without losing your mind"].

Oberlinner C, Lang S, Germann C, Trauth B, Eberle F, Pluto R, Neumann S, Zober A.

Gesundheitswesen. 2007 Jul;69(7):385-92. German.

PMID:
17701837
13.

[Long-term follow-up on alcohol use in a big company after brief intervention by a company physician].

Croissant B, Hupfer K, Loeber S, Mann K, Zober A.

Nervenarzt. 2008 Jan;79(1):80-5. German.

PMID:
17520236
14.

Pregnancy protection program in a large chemical company: infant outcomes.

Frey GM, Ott MG, Messerer P, Nasterlack M, Zober A, Queisser-Luft A.

J Occup Environ Med. 2007 May;49(5):519-25.

PMID:
17495694
15.

Pregnancy protection program in a large chemical company: design and initial survey results.

Frey GM, Ott MG, Messerer P, Nasterlack M, Queisser-Luft A, Zober A.

J Occup Environ Med. 2007 May;49(5):507-18.

PMID:
17495693
16.

Epidemiological and clinical investigations among employees in a former herbicide production process.

Nasterlack M, Hoffmann G, Messerer P, Ott MG, Pallapies D, Wrede M, Zober A.

Int Arch Occup Environ Health. 2007 Jan;80(3):234-8. Epub 2006 Jul 13.

PMID:
16838167
17.

Illness experience before and after an initiative to identify, treat, and prevent Helicobacter pylori-related diseases in the workplace.

Ott MG, Zober A, Messerer P, Riemann JF, Schilling D.

J Occup Environ Med. 2004 Mar;46(3):227-33.

PMID:
15091284
18.

[Precautions for intestinal cancer in the workplace. An initiative for secondary prevention in the BASF joint-stock company].

Webendörfer S, Messerer P, Eberle F, Zober A.

Dtsch Med Wochenschr. 2004 Feb 6;129(6):239-43. German.

PMID:
14750049
19.

Where should the chemicals policy go?

Zober A, Nasterlack M.

Int Arch Occup Environ Health. 2003 Oct;76(8):553-5. Epub 2003 Sep 18. No abstract available.

PMID:
14504958
20.

Environmental medicine in the chemical industry -- the BASF example.

Nasterlack M, Zober A.

Int Arch Occup Environ Health. 2002 Oct;75 Suppl:S14-6. Epub 2002 Jul 4.

PMID:
12397405
21.

IgE-mediated allergy to phytase -- a new animal feed additive.

Baur X, Melching-Kollmuss S, Koops F, Strassburger K, Zober A.

Allergy. 2002 Oct;57(10):943-5.

PMID:
12269943
22.

Response to a case of occupational asthma due to the enzymes phytase and beta-glucanase.

Zober A, Strassburger K, Baur X.

Occup Environ Med. 2002 Jan;59(1):64. No abstract available.

23.

[Dyspepsia and Helicobacter pylori infection in employees of a large industry. Results of a prospective BASF Helicobacter pylori prevention campaign].

Schilling D, Messerer P, Ott MG, Schauwecker P, Zober A, Riemann JF.

Med Klin (Munich). 2002 Jan 15;97(1):6-11. German.

PMID:
11831064
24.
25.
26.

Polymorphism at codon 554 of the human Ah receptor: different allelic frequencies in Caucasians and Japanese and no correlation with severity of TCDD induced chloracne in chemical workers.

Wanner R, Zober A, Abraham K, Kleffe J, Henz BM, Wittig B.

Pharmacogenetics. 1999 Dec;9(6):777-80. No abstract available.

PMID:
10634141
27.

Helicobacter pylori infection: prevalence and clinical relevance in a large company.

Zober A, Schilling D, Ott MG, Schauwecker P, Riemann JF, Messerer P.

J Occup Environ Med. 1998 Jul;40(7):586-94.

PMID:
9675716
29.

BASF studies: epidemiological and clinical investigations on dioxin-exposed chemical workers.

Zober A, Messerer P, Ott MG.

Teratog Carcinog Mutagen. 1997-1998;17(4-5):249-56.

PMID:
9508734
30.

Digestive tract neoplasms among employees with past exposure to brominated dioxins.

Zober A, Ott MG.

Occup Environ Med. 1997 Jan;54(1):66. No abstract available.

33.

Biological monitoring and risk assessment in occupational settings.

Zober A, Will W.

Int Arch Occup Environ Health. 1996;68(6):389-93.

PMID:
8891773
34.

Investigation of a cluster of ten cases of Hodgkin's disease in an occupational setting.

Swaen GM, Slangen JM, Ott MG, Kusters E, Van Den Langenbergh G, Arends JW, Zober A.

Int Arch Occup Environ Health. 1996;68(4):224-8.

PMID:
8738351
35.

Occupational cancer in Europe as it relates to the chemical industry in the 1990's.

Zober A.

Med Lav. 1995 May-Jun;86(3):256-9. No abstract available.

PMID:
7565289
36.

Study of morbidity of personnel with potential exposure to vinclozolin.

Zober A, Hoffmann G, Ott MG, Will W, Germann C, van Ravenzwaay B.

Occup Environ Med. 1995 Apr;52(4):233-41.

37.

Laboratory results for selected target organs in 138 individuals occupationally exposed to TCDD.

Ott MG, Zober A, Germann C.

Chemosphere. 1994 Nov-Dec;29(9-11):2423-37.

PMID:
7850391
40.

Screening for thyroid disorders in a working population.

Schaaf L, Pohl T, Schmidt R, Vardali I, Teuber J, Schlote-Sauter B, Nowotny B, Schiebeler H, Zober A, Usadel KH.

Clin Investig. 1993 Feb;71(2):126-31.

PMID:
8461623
41.

Assessment of past occupational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin using blood lipid analyses.

Ott MG, Messerer P, Zober A.

Int Arch Occup Environ Health. 1993;65(1):1-8.

PMID:
8354568
42.

Cytogenetic studies in lymphocytes of workers exposed to 2,3,7,8-TCDD.

Zober A, Ott MG, Fleig I, Heidemann A.

Int Arch Occup Environ Health. 1993;65(3):157-61.

PMID:
8282413
43.

Thirty-four-year mortality follow-up of BASF employees exposed to 2,3,7,8-TCDD after the 1953 accident.

Zober A, Messerer P, Huber P.

Int Arch Occup Environ Health. 1990;62(2):139-57.

PMID:
2139014
44.

EPAC--a database system for epicrises of occupational examinations in the chemical industry.

Germann C, Messerer P, Zober AM.

Pol J Occup Med. 1989;2(4):350-6.

PMID:
2489436
45.

Cross-sectional study of respiratory effects of arc welding.

Zober A, Weltle D.

J Soc Occup Med. 1985 Autumn;35(3):79-84. No abstract available.

PMID:
4033092
46.

Intoxication following the inhalation of hydrogen fluoride.

Braun J, Stöss H, Zober A.

Arch Toxicol. 1984 Nov;56(1):50-4.

PMID:
6517713
47.

[Nickel and chromium content of selected human organs and body fluids].

Zober A, Kick K, Schaller KH, Schellmann B, Valentin H.

Zentralbl Bakteriol Mikrobiol Hyg B. 1984 Mar;179(1):80-95. German.

PMID:
6720151
48.

[Noise--a stress factor in occupational and other environments].

Zober A.

Zentralbl Bakteriol Mikrobiol Hyg B. 1984 Mar;179(1):1-31. German.

PMID:
6720146
49.

Barium in welding fume.

Dare PR, Hewitt PJ, Hicks R, Van Bemst A, Zober A, Fleischer M.

Ann Occup Hyg. 1984;28(4):445-8. No abstract available.

PMID:
6529074
50.

[Pulmonary fibrosis in an electric welder--clinical case and legal insurance assessment criteria].

Zober A, Kaduk B, Schaller KH.

Zentralbl Arbeitsmed Arbeitsschutz Prophyl Ergonomie. 1983 Apr;33(4):116-20. German. No abstract available.

PMID:
6613373

Supplemental Content

Support Center